Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid-Reference-Cited by-同舟云学术

Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid

Published:2010-03-15 Issue:5 Volume:89 Page:595-599
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

van Gelder Teun,Tedesco Silva Helio,de Fijter Johan W.,Budde Klemens,Kuypers Dirk,Arns Wolfgang,Paul Soulillou Jean,Kanellis John,Zelvys Arunas,Ekberg Henrik,Holzer Herwig,Rostaing Lionel,Mamelok Richard D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference12 articles.

1. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.;Halloran;Transplantation,1997

2. Randomized trial of tacrolimus (prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (neoral) with mycophenolate mofetil after cadaveric kidney transplantation.;Johnson;Transplantation,2000

3. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.;Shaw;Am J Transplant,2003

4. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.;Van Hest;J Am Soc Nephrol,2006

5. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.;Hale;Clin Pharmacol Ther,1998

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better Rejection‐Free Survival at Three Years in Kidney Transplant Recipients With Model‐Informed Precision Dosing of Mycophenolate Mofetil;Clinical Pharmacology & Therapeutics;2024-02-19

2. Association between CYP3A5 Gene Polymorphism and Post-Transplant Acute Immune Rejection in Renal Transplant Recipients Receiving Tacrolimus Therapy: A Correlation Study;Archivos Españoles de Urología;2024

3. Evaluation of mycophenolic acid exposure in a patient with immune-related hepatotoxicity caused by nivolumab and ipilimumab therapy for malignant melanoma: a case report;Cancer Chemotherapy and Pharmacology;2023-12-26

4. The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and Perspectives;Therapeutic Drug Monitoring;2023-02

5. TDM Is Alive and Kicking!;Therapeutic Drug Monitoring;2023-02